Press release
Minimal Residual Disease Testing Market Report 2025-2032 | Trends, Size & Investment Insights
Minimal Residual Disease Testing Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/minimal-residual-disease-testing-market?kb
United States: Recent Industry Developments
✅ November 2025: Adaptive Biotechnologies launched an enhanced MRD assay for early detection of hematologic cancers with improved sensitivity.
✅ October 2025: FDA approved new companion diagnostic tests integrating MRD monitoring for personalized leukemia treatment.
✅ September 2025: Leading diagnostic labs expanded NGS-based MRD testing services to improve patient prognosis tracking.
GCC: Recent Industry Developments
✅ November 2025: Gulf Medical University partnered with global biotech firms to introduce advanced MRD testing capabilities across UAE and Saudi Arabia.
✅ October 2025: Regional hospitals adopted digital pathology platforms to facilitate MRD testing in hematology departments.
✅ September 2025: Government health initiatives funded MRD testing expansion programs targeting early cancer relapse detection.
MENA: Recent Industry Developments
✅ November 2025: Collaboration between MENA oncology centers and diagnostics companies advanced MRD assay standardization.
✅ October 2025: Increased awareness and training programs improved MRD test adoption in Egypt and Jordan healthcare facilities.
✅ September 2025: Investments in molecular diagnostic infrastructure strengthened MRD testing accessibility across the region.
Major Growing Players:
Adaptive Biotechnologies Corp., ARUP Laboratories., Myriad Genetics, Inc., Guardant Health, Natera, Inc., HematoLogics, Inc., Laboratory Corporation of America® Holdings., Twist Bioscience., Invivoscribe, Inc. and Cytognos
Latest M&A/Partnerships
Strategic collaborations dominate:
1. Adaptive Biotechnologies + NeoGenomics (Jan 2025): clonoSEQ MRD integrates with COMPASS/CHART for blood cancers (MM/CLL/ALL/DLBCL).
2. QIAGEN + Tracer/Foresight (Jun 2025): Expands solid tumor MRD via NGS/ddPCR partnerships.
3. Hartwig + Ultima Genomics (Apr 2025): Low-cost whole-genome profiling/MRD for pan-cancer. No outright acquisitions; focus co-development/companion diagnostics (Tier I: Guardant/Exact/Natera; Tier II: emerging NGS).
Forecast Projection:
The Global Minimal Residual Disease Testing Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Global Minimal Residual Disease Testing Market report is built on solid intelligence - powered by both primary and secondary research. Our analysts have deep-dived into every factor that can influence your business roadmap, including government regulations, competitive landscape, tech innovations, historical market behavior, upcoming breakthroughs, adjacent industry trends, market volatility, growth prospects, and potential risks.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=minimal-residual-disease-testing-market?kb
Key Segments:
By Type: (Test Kits, Test Services)
By Technology: (PCR Based, Next-Generation Sequencing, Flow-Cytometry, Others)
By Indication: (Blood Cancers, Solid Cancers, Others)
By End Users: (Hospitals & Clinics, Diagnostic Centers, Cancer Centers, Others)
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: sets the stage by defining the full scope of the report and delivering an executive summary of key market segments across regions, product types, and applications. It provides a comprehensive snapshot of current market sizes and reveals future growth potential, offering a clear vision of how the market will evolve in the short, mid, and long term.
Chapter 2: uncovers critical insights and highlights the most impactful emerging trends shaping the Minimal Residual Disease Testing market's future - essential knowledge for investors and strategists looking to stay ahead.
Chapter 3: dives deep into the competitive landscape, delivering an in-depth analysis of Minimal Residual Disease Testing manufacturers. It covers market share dynamics, strategic developments, and the latest mergers and acquisitions that are redefining the industry.
Chapter 4: profiles the market's leading players, offering detailed views of their revenue streams, profit margins, product portfolios, and recent innovations - arming you with the intel to benchmark and strategize effectively.
Chapters 5 & 6: break down revenue performance by region and country, providing a quantitative analysis that spotlights growth hotspots, development prospects, and the unique opportunities each market offers across the globe.
Chapter 7: explores market segmentation by type, revealing the size and untapped potential of each segment - guiding you toward lucrative "blue ocean" opportunities that competitors may have overlooked.
Chapter 8: analyzes the market by application, evaluating downstream sectors with the highest growth potential and identifying promising areas for expansion and investment.
Chapter 9: maps the entire industry supply chain, tracing upstream suppliers to downstream distributors, giving you full visibility into critical business linkages and value drivers.
Chapter 10: wraps up with a powerful summary of the report's key findings and strategic takeaways, delivering the must-know insights every industry stakeholder needs to make confident, forward-looking decisions.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/minimal-residual-disease-testing-market?kb
Government Regulations
FDA Breakthrough/Endpoints:
1. MRDnegCR qualification (May 2025 EMA-CHMP): Supports conditional approval in myeloma (PFS/OS obligation); unanimous ODAC vote (Apr 2024) enables surrogate endpoints.
2. Haystack MRD (Quest, Aug 2025): FDA Breakthrough Device for ctDNA pan-cancer MRD.
3. Hematologic malignancies guidance (2020, active): MRD as IND biomarker/surrogate; De Novo/510(k) for IVDs. EMA IVDR Class C for high-risk MRD tests (Notified Body/CE mark).
Have Detailed Enquiry of This Report @ https://www.datamintelligence.com/enquiry/minimal-residual-disease-testing-market?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Minimal Residual Disease Testing Market Report 2025-2032 | Trends, Size & Investment Insights here
News-ID: 4298639 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Global Edge Computing for Autonomous Vehicles Market to reach US$ 39.00 billion …
Global edge computing for autonomous vehicles Market reached US$ 7.64 billion in 2024 and is expected to reach US$ 39.00 billion by 2032, growing with a CAGR of 22.60% during the forecast period 2025-2032.
Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/edge-computing-for-autonomous-vehicles-market?pratik
The integration of 5G networks to provide ultra-low latency communication is a key trend driving the edge computing market for autonomous vehicles. Autonomous vehicles rely…
Carbon Capture, Utilization & Storage Market to Hit USD 16.5 Billion by 2031 at …
The Global Carbon Capture, Utilization and Storage Market reached US$ 3.0 billion in 2023 and is projected to grow significantly, reaching US$ 16.5 billion by 2031, at a strong CAGR of 24.0% during 2024-2031. Growing public awareness of climate change and the critical role of CCUS in reducing carbon emissions is driving widespread adoption. Increasing community engagement, educational initiatives and stakeholder participation are strengthening acceptance and accelerating deployment globally.
Collaborative efforts…
Medical Device Cleaning Market Insights | Growth, Trends in GCC and MEA: GAMA He …
Medical Device Cleaning Market is estimated to reach at a high CAGR of 6.29% during the forecast period (2024-2031).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/medical-device-cleaning-market?kb
United States: Recent Industry Developments
✅ September 2025: Steris Corporation launched advanced automated cleaning systems designed for complex surgical instruments, improving sterilization efficacy.
✅ July 2025: FDA updated guidelines emphasizing validation protocols for reprocessing single-use medical devices to…
Healthy Snacks Market Expands to USD 141.6 Billion by 2030 with 6.1% CAGR; North …
The Global Healthy Snacks Market reached US$ 88.2 billion in 2022 and is projected to reach US$ 141.6 billion by 2030, growing at a CAGR of 6.1 percent during the forecast period 2024-2031. Healthy snacks, including meat snacks, nuts and seeds, dried fruits, trail mixes, cereal bars and granola bars, are increasingly becoming a preferred choice among consumers seeking convenient yet nutritious food options. Rising health awareness, clean-label preferences and…
More Releases for MRD
Minimal Residual Disease (MRD) Testing Market Demand in 2034
Rising adoption of next-generation sequencing (NGS), expanded use of MRD in hematologic malignancies, and growing integration of liquid biopsy technologies are propelling strong global market growth.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/50110
Introduction
The Minimal Residual Disease (MRD) Testing Market is expanding rapidly as oncologists and diagnostic laboratories increasingly rely on highly sensitive molecular tests to detect trace levels of cancer cells that persist after treatment. MRD testing-using flow…
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing…
MRD Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 with a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology…
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing…
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031.
According to a market report by Lucintel, the future…
Global MRD Testing Market Set to Reach USD 3.72 Billion by 2030
➤ Global Minimal Residual Disease (MRD) Testing Market to Reach USD 3.72 Billion by 2030, Driven by Technological Advancements and Rising Cancer Incidence
The global Minimal Residual Disease (MRD) Testing Market is projected to expand from USD 1.60 billion in 2023 to USD 3.72 billion by 2030, registering a robust Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period.
➤ Competitive Landscape and Regional Demand
The MRD testing market…
